Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application.

about

Current Clinical Trials on the Use of Ceftaroline in the Pediatric Population.Monitoring and managing antibiotic resistance in refugee children.

P2860

Q39223676-23560621-9102-4B51-8F2B-FEF211176D07 Q46658147-1FC64147-91CA-4A3C-902A-7B98692E083B

P2860

Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application.

Item

http://www.wikidata.org/entity/Q39048083

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application.

@en

Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application.

@nl

type

Item

label

Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application.

@en

Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application.

@nl

prefLabel

Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application.

@en

Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application.

@nl

P1476

Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application

@en

P2093

Jason G Newland

http://www.w3.org/2001/XMLSchema#string

Leah M Molloy

http://www.w3.org/2001/XMLSchema#string

P2860

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

Agranulocytosis in a Pediatric Patient Treated With Ceftaroline.

Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials.

Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycin.

Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Pulmonary Exacerbation in a Pediatric Cystic Fibrosis Patient

Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains.

TAK-599, a novel N-phosphono type prodrug of anti-MRSA cephalosporin T-91825: synthesis, physicochemical and pharmacological properties.

Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp.

New antimicrobial agents for methicillin-resistant Staphylococcus aureus.

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.

P2888

s40121-016-0144-8

P304

57-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40121-016-0144-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Juwon Yim

P577

2016-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28039666

http://www.w3.org/2001/XMLSchema#string

P932

5336419

http://www.w3.org/2001/XMLSchema#string

Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application.

about

P2860

P2860

Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932